Quick Answer
GILEAD SCIENCES, INC. reported Operating Income of $10.02 billion for fiscal year 2025.
GILEAD SCIENCES, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $10.02B | +503.0% |
| 2024 | $1.66B | -78.1% |
| 2023 | $7.61B | +3.8% |
| 2022 | $7.33B | -26.1% |
| 2021 | $9.92B | +143.6% |
| 2020 | $4.07B | -5.0% |
| 2019 | $4.29B | -47.7% |
| 2018 | $8.20B | -41.9% |
| 2017 | $14.12B | -19.9% |
| 2016 | $17.63B | -20.5% |
| 2015 | $22.19B | +45.4% |
| 2014 | $15.27B | +237.4% |
| 2013 | $4.52B | +12.8% |
| 2012 | $4.01B | +5.8% |
| 2011 | $3.79B | -4.4% |
| 2010 | $3.96B | +12.3% |
| 2009 | $3.53B | +31.8% |
| 2008 | $2.68B | +23.7% |
| 2007 | $2.16B | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.33B | +274.7% | +34.5% |
| June 30, 2025 | $2.47B | -6.4% | +10.6% |
| March 31, 2025 | $2.24B | +151.8% | +151.9% |
| September 30, 2024 | $888.00M | -66.1% | -66.4% |
| June 30, 2024 | $2.64B | +58.8% | +161.2% |
| March 31, 2024 | -$4.32B | -353.5% | -264.8% |
| September 30, 2023 | $2.62B | -7.5% | +57.5% |
| June 30, 2023 | $1.67B | -17.9% | -2.3% |
- GILEAD SCIENCES, INC. showed an increase of +503.0% in Operating Income compared to the prior fiscal year.
- Over the 2007–2025 period, GILEAD SCIENCES, INC.’s operating income has grown by 363.0% (from $2.16 billion to $10.02 billion).
- The most recent figure is from GILEAD SCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: